# FDA recall Z-1895-2020

> **Abbott Laboratories** · Class III · device recall initiated 2020-04-01.

## Product

ARCHITECT C Peptide Calibrator - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.

## Reason for recall

Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.

## Distribution

International distributed only in Mexico, no US distribution.

## Key facts

- **Recall number:** Z-1895-2020
- **Recalling firm:** Abbott Laboratories
- **Classification:** Class III
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2020-04-01
- **Report date:** 2020-05-13
- **Termination date:** 2020-09-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Abbott Park, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1895-2020

## Citation

> AI Analytics. FDA recall Z-1895-2020. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/Z-1895-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*